1. Home
  2. News
  3. Alterity Therapeutics Ltd.
  4. Presentation on ATH434 to American Academy of Neurology
More Alterity Therapeutics Ltd. news
Alterity Therapeutics Ltd.ASX: ATH

Presentation on ATH434 to American Academy of Neurology

May 20, 2020 at 10:42 PM EDT · Issued by Alterity Therapeutics Ltd.

Filed with ASX · May 20, 2020 at 10:42 PM EDT · 2 pages · English

On 6ix: 6ix.com/news/presentation-on-ath434-to-american-academy-of-neurology

Alterity Therapeutics Ltd. on 6ix

Earlier from Alterity Therapeutics

  • Appendix 4C and Quarterly UpdateApr 30, 2020
  • NASDAQ Temporary ReliefApr 22, 2020
  • NASDAQ Non-Compliance Notice ReceivedFeb 7, 2020
  • Appendix 4C - quarterlyJan 31, 2020
  • Alterity receives a $4.8 million R&D Tax Incentive RefundJan 14, 2020

Later from Alterity Therapeutics

  • Meeting with US FDA provides development path for ATH434Jun 30, 2020
  • Pause in TradingJul 1, 2020
  • New data independently confirms safety profile of ATH434Aug 4, 2020
  • Preliminary Final ReportAug 30, 2020
  • Company update on Annual Report 2020Sep 9, 2020
All Alterity Therapeutics news releases↗

Follow Alterity Therapeutics into a list and get an email when it puts out news.

Follow Alterity Therapeutics
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer